Moloney Securities Asset Management »

Allogene Therapeutics shares owned by Moloney Securities Asset Management

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Moloney Securities Asset Management from 13F filings

Historical chart of Moloney Securities Asset Management investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Moloney Securities Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Moloney Securities Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $637k 514k 1.24
2025-06-30 $302k 268k 1.13
2025-03-31 $431k 295k 1.46

More positions owned by Moloney Securities Asset Management

Invesco Qqq Trust Series 1 (QQQ)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Spdr S&p 500 Etf (SPY)
RBB (TBIL)
Amazon (AMZN)
Spdr Series Trust dj ttl mkt etf (SPTM)
Alphabet Inc Class A cs (GOOGL)
Berkshire Hathaway (BRK.B)
iShares Dow Jones US Technology (IYW)
iShares S&P 500 Growth Index (IVW)
Facebook Inc cl a (META)
SPDR DJ Wilshire Large Cap (SPLG)
iShares Dow Jones US Financial (IYF)

View all positions for Moloney Securities Asset Management

Top funds holding Allogene Therapeutics

Pfizer
Tpg Gp A
BlackRock
Citadel Advisors
Vanguard Group
PRIMECAP Management Company
Woodline Partners
Frazier Life Sciences Management
Geode Capital Management
UBS Group
Millennium Management
Two Sigma Investments
Patient Square Capital
Wildcat Capital Management
Renaissance Technologies

View all funds holding Allogene Therapeutics